Evidence map›Paper›PMID 31830034›Full record

ReviewPLoS neglected tropical diseases2019

Cutaneous leishmaniasis in Syria: A review of available data during the war years: 2011-2018.

Ghada Muhjazi, Albis Francesco Gabrielli, José Antonio Ruiz-Postigo, Hoda Atta, Mona Osman, Hyam Bashour, Atef Al Tawil, Hania Husseiny, Rasmieh Allahham, Richard Allan

Abstract readReview
In one paragraph

Review in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ghada MuhjaziDepartment of Communicable Disease Prevention and Control, WHO/EMRO Regional Office for the Eastern Mediterranean, Cairo, Egypt.ORCID 0000-0002-8444-8085
Albis Francesco GabrielliDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.
José Antonio Ruiz-PostigoDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.
Hoda AttaDepartment of Communicable Disease Prevention and Control, WHO/EMRO Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Mona OsmanDepartment of Communicable Disease Prevention and Control, WHO/EMRO Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Hyam BashourDamascus University, Damascus, Syria.
Atef Al TawilMinistry of Health, Damascus, Syria.
Hania HusseinySyria WHO Country Office, World Health Organization, Damascus, Syria.
Rasmieh AllahhamSyria WHO Country Office, World Health Organization, Damascus, Syria.
Richard AllanThe MENTOR Initiative, Crawley, United Kingdom.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundCutaneous leishmaniasis (CL) has historically been reported from Syria. Since 2011, the country has been affected by a war, which has impacted health and health services. Over the same period, an increase in the number of cases of CL has been reported from several areas across the country and by a number of authors. This study aims to provide the first quantitative evidence of the epidemiological evolution of CL in Syria during the war. MATERIALS AND

methodsData on number of CL cases for the period 2011-2018 were extracted from three different surveillance systems: the Ministry of Health (MoH) routine surveillance system, the MoH/WHO sentinel-syndromic Early Warning Alert and Response System (EWARS), and surveillance data collected by the international nongovernmental organization (NGO) the MENTOR Initiative. Data were cleaned and merged to generate the best possible estimates on number of CL cases; incidence of CL was also calculated based on data on resident population. Data reported from the years preceding the conflict (2007-2010) were also added to the analysis for comparative purposes.

resultsThe analysis of data from the three available sources over the period considered indicates that number of reported cases progressively grew from prewar levels to reach a peak in 2015, decreased in 2016, remained stable in 2017, and increased again in 2018. Such a trend was mirrored by changes in incidence of infection. Some governorates, which used to report low numbers of CL cases, started recording higher number of cases after the onset of the war.

conclusionThe war coincided with a major rise in reported number of CL cases and incidence of infection, although an increasing trend was already appreciable before its onset.

Indexed as

Armed ConflictsHumansIncidenceLeishmaniasis, CutaneousPrevalenceSyria

Identifiers

PMID31830034
PMCPMC6907761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.